TLR9 and metabolic dysfunction-associated steatohepatitis: The critical mass of research supporting TLR9’s importance in the pathogenesis of NASH and NASH-associated fibrosis includes an integral role in the inflammatory process that fuels NASH, as well as a metabolic one.